Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis
Open accessThe DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
The role of the mesenchymal stromal cell- (MSC-) derived secretome is becoming increasingly intriguing from a clinical perspective due to its ability to stimulate endogenous tissue repair processes as well as its effective regulation of the immune system, mimicking the therapeutic effects produced by the MSCs. The secretome is a composite product secreted by MSC in vitro (in conditioned medium) and in vivo (in the extracellular milieu), consisting of a protein soluble fraction (mostly growth factors and cytokines) and a vesicular component, extracellular vesicles (EVs), which transfer proteins, lipids, and genetic material. MSC-derived secretome differs based on the tissue from which the MSCs are isolated and under specific conditions (e.g., preconditioning or priming) suggesting that clinical applications should be tailored by choosing the tissue of origin and a priming regimen to specifically correct a given pathology. MSC-derived secretome mediates beneficial angiogenic effects in a variety of tissue injury-related diseases. This supports the current effort to develop cell-free therapeutic products that bring both clinical benefits (reduced immunogenicity, persistence in vivo , and no genotoxicity associated with long-term cell cultures) and manufacturing advantages (reduced costs, availability of large quantities of off-the-shelf products, and lower regulatory burden). In the present review, we aim to give a comprehensive picture of the numerous components of the secretome produced by MSCs derived from the most common tissue sources for clinical use (e.g., AT, BM, and CB). We focus on the factors involved in the complex regulation of angiogenic processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The overall presence and concentration of angiogenic factors within the CM were found to be superior in BM preparations with increased relative levels of tubulogenesis-driving factors such as VEGF [39, 40].”
From Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentre manufacturing approach (2023) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gong, X., Liu, H., Wang, S., Liang, S., & Wang, G. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28070 · Cited by 140
RetractedMultilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 2×
“To differentiate MSCs from other morphologically similar cells, the International Society for Cellular Therapy (ISCT) defined the minimal set of criteria by which MSCs are identified: adherence to plastic under normal cell culture conditions; differentiation capability into multiple cell lineages including, and not li…”
BackgroundThéry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · cited 1×
“quality/purity of isolated EVs in order to confidently report biological cargo or functions to EVs [38].”
BackgroundCaplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186 · cited 2×
“Cells secrete a wide range of EVs that differ in size, origin, content, and function [37].”
BackgroundMesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746 · cited 1×
“As an example, MSCs can differentiate into endotheliocytes and myocytes in the mesoderm under conditional induction [84].”
BackgroundCommunication by Extracellular Vesicles: Where We Are and Where We Need to Go
Tkach, M., & Théry, C. (2016) · Cell · doi:10.1016/j.cell.2016.01.043 · Cited by 3,444 · cited 2×
“Recently, it has become apparent that secreted EVs are proficient intercellular communication mediators through the transfer of their cargo to target cells and their ability to influence the behavior of recipient cells [36].”
BackgroundMesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992 · cited 1×
“While it was initially conceived that MSCs exerted their therapeutic effects by migrating to targeted sites of injury and actively contributed to tissue repair and regeneration, it is now increasingly acknowledged that MSCs do not typically engraft after transplantation, due to the phenomena of lung sequestration and…”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“Mesenchymal stromal cells (MSCs) were described for the first time in 1970 by Alexander Friedenstein as a “population of bone marrow stromal cells capable of mesodermal differentiation and trophic support of hematopoiesis” [1, 2].”
BackgroundThe Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones
Cech, T. R., & Steitz, J. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.008 · Cited by 2,524 · cited 1×
“, ribosomal RNA, transfer RNA, miRNA, small interfering RNA (siRNA), and piwi-associated RNA (piRNA)), and long (lncRNAs) if they have more than 200nt [60].”
BackgroundExosome secreted by MSC reduces myocardial ischemia/reperfusion injury
Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S. K., Choo, A., Chen, T. S., Salto-Tellez, M., Timmers, L., Lee, C. N., El Oakley, R. M., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.12.003 · Cited by 2,215
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
Murry, C. E., Soonpaa, M. H., Reinecke, H., Nakajima, H., Nakajima, H. O., Rubart, M., Pasumarthi, K. B. S., Ismail Virag, J., Bartelmez, S. H., Poppa, V., et al. (2004) · Nature · doi:10.1038/nature02446 · Cited by 2,154
Lee, R. H., Pulin, A. A., Seo, M. J., Kota, D. J., Ylostalo, J., Larson, B. L., Semprun-Prieto, L., Delafontaine, P., & Prockop, D. J. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.003 · Cited by 1,898 · cited 1×
“While it was initially conceived that MSCs exerted their therapeutic effects by migrating to targeted sites of injury and actively contributed to tissue repair and regeneration, it is now increasingly acknowledged that MSCs do not typically engraft after transplantation, due to the phenomena of lung sequestration and…”
BackgroundConcise review: MSC-derived exosomes for cell-free therapy
Phinney, D. G., & Pittenger, M. F. (2017) · Stem Cells · doi:10.1002/stem.2575 · Cited by 1,834
Hass, R., Kasper, C., Böhm, S., & Jacobs, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-12 · Cited by 1,748
Caplan, A. I., & Correa, D. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.008 · Cited by 1,682 · cited 1×
“MSCs have generated considerable interest in the field of tissue regeneration and hold promising potential as a therapeutic approach due to their ability to enhance angiogenesis and accelerate tissue healing [15].”
BackgroundMesenchymal stem cells: immune evasive, not immune privileged
Ankrum, J. A., Ong, J. F., & Karp, J. M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2816 · Cited by 1,531 · cited 1×
“While it was initially conceived that MSCs exerted their therapeutic effects by migrating to targeted sites of injury and actively contributed to tissue repair and regeneration, it is now increasingly acknowledged that MSCs do not typically engraft after transplantation, due to the phenomena of lung sequestration and…”
BackgroundExoCarta: A Web-Based Compendium of Exosomal Cargo
Keerthikumar, S., Chisanga, D., Ariyaratne, D., Al Saffar, H., Anand, S., Zhao, K., Samuel, M., Pathan, M., Jois, M., Chilamkurti, N., et al. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.09.019 · Cited by 1,452 · cited 1×
“MSC-derived secretome performs its angiogenic modulation through a complex synergic activity between many bioactive molecules carried by EVs, such as microRNA (miRNA), transfer RNA (tRNA), long noncoding RNA (lncRNA), growth factors, proteins, and lipids [39].”
BackgroundFriedenstein, A. J., Chailakhyan, R. K., Latsinik, N. V., Panasyuk, A. F., & Keiliss-Borok, I. V. (1974) · Transplantation · doi:10.1097/00007890-197404000-00001 · Cited by 1,431
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Bernardo, M. E., & Fibbe, W. E. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.09.006 · Cited by 1,383 · cited 1×
“inflammatory and immunomodulatory effects [8], as well as tissue regeneration, including healing of chronic wounds, regeneration of cartilage, angiogenesis, and vascularization following pathological conditions such as myocardial infarction, brain injury, and limb ischemia [9–14].”
BackgroundIdentification of Tim4 as a phosphatidylserine receptor
Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., & Nagata, S. (2007) · Nature · doi:10.1038/nature06307 · Cited by 1,180 · cited 1×
“In addition, the fate of EVs depends on the interaction of specific receptors with vesicular phosphatidylserine and lysophosphatidylcholine [97].”
BackgroundTögel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., & Westenfelder, C. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00007.2005 · Cited by 1,178 · cited 1×
“While it was initially conceived that MSCs exerted their therapeutic effects by migrating to targeted sites of injury and actively contributed to tissue repair and regeneration, it is now increasingly acknowledged that MSCs do not typically engraft after transplantation, due to the phenomena of lung sequestration and…”
BackgroundGnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhang, L., Morello, F., Mu, H., Melo, L. G., Pratt, R. E., Ingwall, J. S., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5211com · Cited by 1,157 · cited 1×
“[27], are due to numerous secreted elements collectively referred to as the secretome [28].”
BackgroundMSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease
Kordelas, L., Rebmann, V, Ludwig, A.-K., Radtke, S., Ruesing, J., Doeppner, T. R., Epple, M., Horn, P. A., Beelen, D. W., & Giebel, B. (2014) · Leukemia · doi:10.1038/leu.2014.41 · Cited by 1,084 · cited 1×
“Nonetheless, one limited clinical report has been published in a different clinical setting (refractory graft versus host disease) [126].”
BackgroundPepper, M. S., Ferrara, N., Orci, L., & Montesano, R. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92277-5 · Cited by 858 · cited 1×
“FGF-2 modulates angiogenesis with autocrine mechanism [119], together with VEGF, has a potent synergistic effect on the induction of angiogenesis in vivo [120], and supports long-term angiogenic efficacy of AT-MSCs in ischemic mouse tissues [121].”
BackgroundRecord, M., Carayon, K., Poirot, M., & Silvente-Poirot, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.10.004 · Cited by 852 · cited 1×
“As part of vesicle membranes, EV lipids provide the structural rigidity and stability required during the budding process as well as the ability to protect EV cargo, promoting autocrine or paracrine signaling [89, 94].”
BackgroundTraktuev, D. O., Merfeld-Clauss, S., Li, J., Kolonin, M., Arap, W., Pasqualini, R., Johnstone, B. H., & March, K. L. (2008) · Circulation Research · doi:10.1161/circresaha.107.159475 · Cited by 839
Molecular lipidomics of exosomes released by PC-3 prostate cancer cells
Llorente, A., Skotland, T., Sylvänne, T., Kauhanen, D., Róg, T., Orłowski, A., Vattulainen, I., Ekroos, K., & Sandvig, K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.04.011 · Cited by 768
Baglio, S. R., Rooijers, K., Koppers-Lalic, D., Verweij, F. J., Pérez Lanzón, M., Zini, N., Naaijkens, B., Perut, F., Niessen, H. W. M., Baldini, N., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0116-z · Cited by 765 · cited 3×
“Unlike the parent cell, MSC-derived-EVs are highly enriched in the class of tRNAs (more than 50% of total small RNAs in AT-derived EVs and 23–35% in BM-derived EVs) [79].”
BackgroundHaraszti, R. A., Didiot, M., Sapp, E., Leszyk, J., Shaffer, S. A., Rockwell, H. E., Gao, F., Narain, N. R., DiFiglia, M., Kiebish, M. A., et al. (2016) · Journal of Extracellular Vesicles · doi:10.3402/jev.v5.32570 · Cited by 746 · cited 3×
“EVs released from different cell sources have distinct lipid content [92].”
BackgroundInfluentialShabbir, A., Cox, A., Rodriguez-Menocal, L., Salgado, M., & Badiavas, E. V. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0316 · Cited by 718
Bian, S., Zhang, L., Duan, L., Wang, X., Min, Y., & Yu, H. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1110-5 · Cited by 710 · cited 1×
“Similar observations were made in vivo using an acute myocardial infarction rat model, where intramyocardial injection of MSC-EVs was found to markedly enhance cardiac repair [46].”
ResultApoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation
Galleu, A., Riffo-Vasquez, Y., Trento, C., Lomas, C., Dolcetti, L., Cheung, T. S., von Bonin, M., Barbieri, L., Halai, K., Ward, S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7828 · Cited by 646 · cited 1×
“While it was initially conceived that MSCs exerted their therapeutic effects by migrating to targeted sites of injury and actively contributed to tissue repair and regeneration, it is now increasingly acknowledged that MSCs do not typically engraft after transplantation, due to the phenomena of lung sequestration and…”
BackgroundFreeman, G. J., Casasnovas, J. M., Umetsu, D. T., & DeKruyff, R. H. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00903.x · Cited by 614 · cited 1×
“These interactions allow intercellular communications [98], chemoattraction [99], and apoptosis [100].”
BackgroundLiang, X., Zhang, L., Wang, S., Han, Q., & Zhao, R. C. (2016) · Journal of Cell Science · doi:10.1242/jcs.170373 · Cited by 554 · cited 1×
“miR-125a Human adipose tissue Induction of angiogenesis through the repression of DLL4 expression [65]”
BackgroundProteomics, transcriptomics and lipidomics of exosomes and ectosomes
Choi, D., Kim, D., Kim, Y., & Gho, Y. S. (2013) · PROTEOMICS · doi:10.1002/pmic.201200329 · Cited by 514 · cited 1×
“2- to 3-fold enrichment from cells to MVs of cholesterol, glycosphingolipids, and phosphatidylserine [91–93] and a reduction of phosphatidylcholine [90].”
BackgroundMesenchymal‐stem‐cell‐derived exosomes accelerate skeletal muscle regeneration
Nakamura, Y., Miyaki, S., Ishitobi, H., Matsuyama, S., Nakasa, T., Kamei, N., Akimoto, T., Higashi, Y., & Ochi, M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.03.031 · Cited by 511
Harrell, C., Fellabaum, C., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8050467 · Cited by 501
Turinetto, V., Vitale, E., & Giachino, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071164 · Cited by 486 · cited 1×
“It has also been reported that MSCs lose their multipotency and undergo senescence during prolonged in vitro culture [102] and this can partly be attributed to a decrease in omega-6 fatty acids which in turn decreases membrane fluidity [103].”
BackgroundZhang, B., Wu, X., Zhang, X., Sun, Y., Yan, Y., Shi, H., Zhu, Y., Wu, L., Pan, Z., Zhu, W., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0267 · Cited by 477 · cited 1×
“Mechanistically, Wnt4 was identified in EVs derived from human CB-MSCs and was shown to induce β-catenin activation in endothelial cells leading to enhanced angiogenesis [58].”
BackgroundYu, B., Kim, H. W., Gong, M., Wang, J., Millard, R. W., Wang, Y., Ashraf, M., & Xu, M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.043 · Cited by 473 · cited 1×
“miR-19a Rat bone marrow (GATA-4-overexpressing MSC) Cardioprotection by increasing survival and angiogenesis [72, 73]”
BackgroundRecruitment of mesenchymal stem cells into prostate tumours promotes metastasis
Jung, Y., Kim, J. K., Shiozawa, Y., Wang, J., Mishra, A., Joseph, J., Berry, J. E., McGee, S., Lee, E., Sun, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms2766 · Cited by 423
Kusuma, G. D., Carthew, J., Lim, R., & Frith, J. E. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0349 · Cited by 413 · cited 1×
“[125] (Figure 3 provides schematic representation).”
Hsiao, S. T.-F., Asgari, A., Lokmic, Z., Sinclair, R., Dusting, G. J., Lim, S. Y., & Dilley, R. J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0674 · Cited by 410 · cited 7×
“Likewise, MCP, RANTES, SCF, and SDF-1 have shown variations in the CM of MSCs of different origins, while high levels of IL-6 are usually constantly retrieved [40].”
BackgroundInfluentialGong, M., Yu, B., Wang, J., Wang, Y., Liu, M., Paul, C., Millard, R. W., Xiao, D.-S., Ashraf, M., & Xu, M. (2017) · Oncotarget · doi:10.18632/oncotarget.16778 · Cited by 399 · cited 1×
“miR-30b Not available Promotion of angiogenesis in vitro and in vivo [75]”
BackgroundToma, C., Wagner, W. R., Bowry, S., Schwartz, A., & Villanueva, F. (2009) · Circulation Research · doi:10.1161/circresaha.108.187724 · Cited by 366
The microRNA regulatory landscape of MSC-derived exosomes: a systems view
Ferguson, S. W., Wang, J., Lee, C. J., Liu, M., Neelamegham, S., Canty, J. M., & Nguyen, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-19581-x · Cited by 360 · cited 4×
“Functional testing of these EVs revealed that MSC-EVs were able to protect cardiomyocytes from apoptosis and increased angiogenesis in HUVECs [70].”
BackgroundInfluentialBronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., & Lambrichts, I. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.013 · Cited by 354
Marquez-Curtis, L. A., Janowska-Wieczorek, A., McGann, L. E., & Elliott, J. A. W. (2015) · Cryobiology · doi:10.1016/j.cryobiol.2015.07.003 · Cited by 346
Salomon, C., Ryan, J., Sobrevia, L., Kobayashi, M., Ashman, K., Mitchell, M., & Rice, G. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068451 · Cited by 341
Lopatina, T., Bruno, S., Tetta, C., Kalinina, N., Porta, M., & Camussi, G. (2014) · Cell Communication and Signaling · doi:10.1186/1478-811x-12-26 · Cited by 309 · cited 1×
“Indeed, compared to unstimulated cells, PDGF-stimulated MSCs release EVs carrying angiogenic c-kit, stem cell factor (SCF), and matrix metalloproteinases (MMPs) [43].”
BackgroundSTAT3: A critical transcription activator in angiogenesis
Chen, Z., & Han, Z. C. (2008) · Medicinal Research Reviews · doi:10.1002/med.20101 · Cited by 305 · cited 1×
“Mechanistically, MSC-derived EVs were found to be enriched with transcriptionally active-signal transducer and activator of transcription 3 (STAT3), which was shown to control many aspects of angiogenesis by regulating VEGF expression at the transcriptional levels [47, 48].”
BackgroundBeyond mass spectrometry, the next step in proteomics
Timp, W., & Timp, G. (2020) · Science Advances · doi:10.1126/sciadv.aax8978 · Cited by 302 · cited 1×
“New technological and bioinformatics advances in mass spectrometry bring this closer to reality [132].”
BackgroundEirin, A., Riester, S. M., Zhu, X.-Y., Tang, H., Evans, J. M., O'Brien, D., van Wijnen, A. J., & Lerman, L. O. (2014) · Gene · doi:10.1016/j.gene.2014.08.041 · Cited by 294
Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System
Baldwin, M. E., Halford, M. M., Roufail, S., Williams, R. A., Hibbs, M. L., Grail, D., Kubo, H., Stacker, S. A., & Achen, M. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2441-2449.2005 · Cited by 289
Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications
Tao, H., Han, Z., Han, Z. C., & Li, Z. (2016) · Stem Cells International · doi:10.1155/2016/1314709 · Cited by 276 · cited 1×
“MSCs release in the extracellular space a plethora of angiogenic factors including basic fibroblast growth factor (bFGF), VEGF, transforming growth factor-beta (TGF-β), PDGF, ANG-1, placental growth factor (PIGF), IL-6, hepatocyte growth factor (HGF), and monocyte chemoattractant protein 1 (MCP-1), which stimulate ang…”
BackgroundEnhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21
Wang, K., Jiang, Z., Webster, K. A., Chen, J., Hu, H., Zhou, Y., Zhao, J., Wang, L., Wang, Y., Zhong, Z., et al. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0386 · Cited by 274 · cited 1×
“miR-21-5p Human endometrium Cardioprotection and enhancing microvessel density in a rat model of myocardial infarction [78] 4 Stem Cells International”
MethodZhang, H.-C., Liu, X.-B., Huang, S., Bi, X.-Y., Wang, H.-X., Xie, L.-X., Wang, Y.-Q., Cao, X.-F., Lv, J., Xiao, F.-J., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0095 · Cited by 267
Ma, T., Chen, Y., Chen, Y., Meng, Q., Sun, J., Shao, L., Yu, Y., Huang, H., Hu, Y., Yang, Z., et al. (2018) · Stem Cells International · doi:10.1155/2018/3290372 · Cited by 259
IWASE, T., NAGAYA, N., FUJII, T., ITOH, T., MURAKAMI, S., MATSUMOTO, T., KANGAWA, K., & KITAMURA, S. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.02.006 · Cited by 258
Zhao, Y., Sun, X., Cao, W., Ma, J., Sun, L., Qian, H., Zhu, W., & Xu, W. (2015) · Stem Cells International · doi:10.1155/2015/761643 · Cited by 257
The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke
Cunningham, C. J., Redondo-Castro, E., & Allan, S. M. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18776802 · Cited by 242 · cited 6×
“They increase the production of VEGF, bFGF, HGF, IGF, and TGF-β [10, 30] and induce lipid and metabolic modifications within the cells and secreted EVs, as described above [106].”
BackgroundInfluentialLin, K.-C., Yip, H.-K., Shao, P.-L., Wu, S.-C., Chen, K.-H., Chen, Y.-T., Yang, C.-C., Sun, C.-K., Kao, G.-S., Chen, S.-Y., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.061 · Cited by 241 · cited 1×
“Similarly, EVs, along with AT-MSCs, were also able to protect rat kidney from acute ischemia-reperfusion injury through the induction of angiogenesis, reflected by the increase of the angiogenic factors CD31, vWF, and angiopoietin [45].”
BackgroundAdipose-Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA-31
Kang, T., Jones, T. M., Naddell, C., Bacanamwo, M., Calvert, J. W., Thompson, W. E., Bond, V. C., Chen, Y. E., & Liu, D. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0177 · Cited by 237 · cited 1×
“miR-31 Human adipose tissue Promotion of angiogenesis in HUVECs by targeting the antiangiogenic HIF-1 gene [77]”
BackgroundXue, C., Shen, Y., Li, X., Li, B., Zhao, S., Gu, J., Chen, Y., Ma, B., Wei, J., Han, Q., et al. (2018) · Stem Cells and Development · doi:10.1089/scd.2017.0296 · Cited by 232 · cited 2×
“Likewise, human umbilical vein endothelial cells (HUVECs) exposed to EVs from hypoxic AT-MSCs significantly upregulated angiogenesis-stimulating genes such as angiopoietin(ANG-) 1 and VEGF receptor 2 [53].”
BackgroundOhnishi, S., Yasuda, T., Kitamura, S., & Nagaya, N. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0347 · Cited by 222
Mesenchymal Stromal Cell Characteristics Vary Depending on Their Origin
Wegmeyer, H., Bröske, A.-M., Leddin, M., Kuentzer, K., Nisslbeck, A. K., Hupfeld, J., Wiechmann, K., Kuhlen, J., von Schwerin, C., Stein, C., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0016 · Cited by 218 · cited 4×
“Du and colleagues paradoxically found that the CM of BM-MSCs and placental MSCs were more proangiogenic than those of AT-MSCs and umbilical cord-derived MSCs [113]. bFGF is not consistently found in the secretome regardless of the MSC source, even after stimulation with TNF-α and IFN-γ [111].”
BackgroundInfluentialExosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells
Luther, K. M., Haar, L., McGuinness, M., Wang, Y., Lynch IV, T. L., Phan, A., Song, Y., Shen, Z., Gardner, G., Kuffel, G., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.04.012 · Cited by 212 · cited 1×
“miR-21a-5p Mouse bone marrow Cardioprotection through inhibition of proapoptotic genes; in silico data support a role in angiogenesis [76]”
BackgroundT cell chemotaxis to lysophosphatidylcholine through the G2A receptor
Radu, C. G., Yang, L. V., Riedinger, M., Au, M., & Witte, O. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536801100 · Cited by 210 · cited 1×
“These interactions allow intercellular communications [98], chemoattraction [99], and apoptosis [100].”
BackgroundGangadaran, P., Rajendran, R. L., Lee, H. W., Kalimuthu, S., Hong, C. M., Jeong, S. Y., Lee, S.-W., Lee, J., & Ahn, B.-C. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.022 · Cited by 210 · cited 2×
“miR-210-3p Mouse bone marrow Acceleration of recovery of hindlimb ischemia through the promotion of angiogenesis [50]”
BackgroundMignatti, P., Morimoto, T., & Rifkin, D. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11007 · Cited by 209 · cited 1×
“FGF-2 modulates angiogenesis with autocrine mechanism [119], together with VEGF, has a potent synergistic effect on the induction of angiogenesis in vivo [120], and supports long-term angiogenic efficacy of AT-MSCs in ischemic mouse tissues [121].”
BackgroundVrijsen, K. R., Maring, J. A., Chamuleau, S. A. J., Verhage, V., Mol, E. A., Deddens, J. C., Metz, C. H. G., Lodder, K., van Eeuwijk, E. C. M., van Dommelen, S. M., et al. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600308 · Cited by 204 · cited 1×
“Moreover, analysis of proangiogenic factors from BM-MSC-derived EVs capable of inducing endothelial cell migration through extracellular signal-regulated kinase (ERK)/Akt signaling revealed the presence of high levels of extracellular matrix metalloproteinase inducer (EMMPRIN) in these vesicles [49].”
BackgroundExosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis
Komaki, M., Numata, Y., Morioka, C., Honda, I., Tooi, M., Yokoyama, N., Ayame, H., Iwasaki, K., Taki, A., Oshima, N., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0660-9 · Cited by 201
Du, W. J., Chi, Y., Yang, Z. X., Li, Z. J., Cui, J. J., Song, B. Q., Li, X., Yang, S. G., Han, Z. B., & Han, Z. C. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0418-9 · Cited by 200 · cited 2×
“VEGF-A, HGF, bFGF, ANG-1 AM-MSC AT-MSC [113]”
ResultMultiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis
Kwon, H. M., Hur, S.-M., Park, K.-Y., Kim, C.-K., Kim, Y.-M., Kim, H.-S., Shin, H.-C., Won, M.-H., Ha, K.-S., Kwon, Y.-G., et al. (2014) · Vascular Pharmacology · doi:10.1016/j.vph.2014.06.004 · Cited by 198 · cited 6×
“VEGF and TGF-β1 secreted in the CM promote angiogenesis and activate PI3K/Akt and MAPK pathways [9, 108]; HGF exhibits angiogenic properties on its own by inducing the expression of VEGF.”
BackgroundInfluentialKehl, D., Generali, M., Mallone, A., Heller, M., Uldry, A.-C., Cheng, P., Gantenbein, B., Hoerstrup, S. P., & Weber, B. (2019) · npj Regenerative Medicine · doi:10.1038/s41536-019-0070-y · Cited by 197 · cited 16×
“FGF-2 modulates angiogenesis with autocrine mechanism [119], together with VEGF, has a potent synergistic effect on the induction of angiogenesis in vivo [120], and supports long-term angiogenic efficacy of AT-MSCs in ischemic mouse tissues [121].”
BackgroundInfluentialWang, Y., Zhang, Z., Chi, Y., Zhang, Q., Xu, F., Yang, Z., Meng, L., Yang, S., Yan, S., Mao, A., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.480 · Cited by 185
Merfeld-Clauss, S., Gollahalli, N., March, K. L., & Traktuev, D. O. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0635 · Cited by 181
Bari, E., Perteghella, S., Di Silvestre, D., Sorlini, M., Catenacci, L., Sorrenti, M., Marrubini, G., Rossi, R., Tripodo, G., Mauri, P., et al. (2018) · Cells · doi:10.3390/cells7110190 · Cited by 176 · cited 1×
“Thus, the appropriate therapeutic use of the MSC secretome as an active pharmaceutical ingredient as well as a drug delivery system [32] relies on the systematic quantitative and functional assessment of the MSC-secreted effectors from the perspective of specific clinical settings, e.”
BackgroundKachgal, S., & Putnam, A. J. (2011) · Angiogenesis · doi:10.1007/s10456-010-9194-9 · Cited by 175
Conrad, C., Niess, H., Huss, R., Huber, S., von Luettichau, I., Nelson, P. J., Ott, H. C., Jauch, K.-W., & Bruns, C. J. (2009) · Circulation · doi:10.1161/circulationaha.108.793208 · Cited by 170
Yang, Y., Cai, Y., Zhang, Y., Liu, J., & Xu, Z. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1071-9 · Cited by 170 · cited 2×
“miR-181b-5p is carried in AT-MSC-derived EVs and enhances the mobility and angiogenesis of brain microvascular endothelial cells (BMECs) after oxygen-glucose deprivation by targeting transient receptor potential melastatin 7 (TRPM7) expression [63].”
BackgroundLiu, L., Gao, J., Yuan, Y., Chang, Q., Liao, Y., & Lu, F. (2013) · Cell Biology International · doi:10.1002/cbin.10097 · Cited by 168 · cited 6×
“They increase the production of VEGF, bFGF, HGF, IGF, and TGF-β [10, 30] and induce lipid and metabolic modifications within the cells and secreted EVs, as described above [106].”
BackgroundInfluentialMoon, G. J., Sung, J. H., Kim, D. H., Kim, E. H., Cho, Y. H., Son, J. P., Cha, J. M., & Bang, O. Y. (2019) · Translational Stroke Research · doi:10.1007/s12975-018-0668-1 · Cited by 166 · cited 1×
“miR-210 Mouse bone marrow Promotion of angiogenesis in a mouse myocardial infarction model through the repression of Efna3 expression in endothelial cells [66, 74]”
BackgroundMesenchymal stem cells as a treatment for neonatal ischemic brain damage
van Velthoven, C. T. J., Kavelaars, A., & Heijnen, C. J. (2012) · Pediatric Research · doi:10.1038/pr.2011.64 · Cited by 165
Han, Y.-D., Bai, Y., Yan, X., Ren, J., Zeng, Q., Li, X., Pei, X., & Han, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.076 · Cited by 165 · cited 1×
“Using a mouse model of subcutaneous fat grafting, hypoxic MSC-EVs from AT were capable of effectively promoting the survival of grafts and neovascularization (increased CD31-positive cells) [52].”
BackgroundLipid, Protein, and MicroRNA Composition Within Mesenchymal Stem Cell-Derived Exosomes
Deng, H., Sun, C., Sun, Y., Li, H., Yang, L., Wu, D., Gao, Q., & Jiang, X. (2018) · Cellular Reprogramming · doi:10.1089/cell.2017.0047 · Cited by 163 · cited 1×
“Possible bioactive lipids contained in MSC-derived EVs include leukotrienes, arachidonic acid, phosphatidic acid, prostaglandins, lysophosphatidylcholine, and docosahexaenoic acid [96].”
BackgroundPu, C.-M., Liu, C.-W., Liang, C.-J., Yen, Y.-H., Chen, S.-H., Jiang-Shieh, Y.-F., Chien, C.-L., Chen, Y.-C., & Chen, Y.-L. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.030 · Cited by 160
Riggi, N., Cironi, L., Provero, P., Suvà, M.-L., Stehle, J.-C., Baumer, K., Guillou, L., & Stamenkovic, I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3979 · Cited by 154
Eirin, A., Zhu, X.-Y., Puranik, A. S., Woollard, J. R., Tang, H., Dasari, S., Lerman, A., van Wijnen, A. J., & Lerman, L. O. (2016) · Scientific Reports · doi:10.1038/srep36120 · Cited by 154 · cited 1×
“The enriched angiogenic proteins identified in EVs comprise VEGF, von Willebrand factor (vWF), and transforming growth factor(TGF-) β1 [41, 42].”
BackgroundMcBride, J. D., Rodriguez-Menocal, L., Guzman, W., Candanedo, A., García-Contreras, M., & Badiavas, E. V. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0087 · Cited by 149 · cited 1×
“Furthermore, wingless-related integration site 3a (Wnt3a) was also described as a cargo of a subpopulation of EVs (CD63+) capable of inducing angiogenesis in vitro [51].”
BackgroundBian, X., Ma, K., Zhang, C., & Fu, X. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1276-z · Cited by 146 · cited 1×
“As a result of EVs’ high lipid content, they have an inherent capacity to pass through biological barriers and escape from phagocytosis by the reticuloendothelial system, while being biocompatible and immunologically inert [88, 95].”
BackgroundLi, H., Zuo, S., He, Z., Yang, Y., Pasha, Z., Wang, Y., & Xu, M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00557.2010 · Cited by 145 · cited 1×
“miR-19a Rat bone marrow (GATA-4-overexpressing MSC) Cardioprotection by increasing survival and angiogenesis [72, 73]”
BackgroundStability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy
Binato, R., de Souza Fernandez, T., Lazzarotto‐Silva, C., Du Rocher, B., Mencalha, A., Pizzatti, L., Bouzas, L. F., & Abdelhay, E. (2013) · Cell Proliferation · doi:10.1111/cpr.12002 · Cited by 132
Mesenchymal stem cells secretome: current trends and future challenges
Teixeira, F., & Salgado, A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.264455 · Cited by 125 · cited 1×
“Challenges and constraints in clinical-grade production of MSC secretome, choice of MSC source (likely to be specifically addressed per each disease setting), and preconditioning have been recently reviewed by Teixeira and Salgado [127].”
Gnecchi, M., He, H., Melo, L. G., Noiseux, N., Morello, F., de Boer, R. A., Zhang, L., Pratt, R. E., Dzau, V. J., & Ingwall, J. S. (2009) · Stem Cells · doi:10.1002/stem.12 · Cited by 124 · cited 1×
“The Akt/Nrf2 pathway plays a crucial role in promoting the angiogenic-related functions of BM-MSCs [117], as demonstrated during infarction, where MSCs overexpressing AKT1 are able to preserve normal pH levels in the surviving myocardium [118].”
BackgroundLuca, L. D., Trino, S., Laurenzana, I., Simeon, V., Calice, G., Raimondo, S., Podestà, M., Santodirocco, M., Mauro, L. D., Rocca, F. L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6791 · Cited by 123 · cited 1×
“tRNAs, along with piRNAs, contribute to maintaining stem cell potency [79], promoting cell survival and inhibiting cell differentiation of CB hematopoietic stem cells [80].”
BackgroundLong non-coding RNA MIAT in development and disease: a new player in an old game
Sun, C., Huang, L., Li, Z., Leng, K., Xu, Y., Jiang, X., & Cui, Y. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0427-3 · Cited by 117 · cited 1×
“MSC-derived lncRNAs have been shown to support angiogenesis through the endothelial differentiation of MSCs: myocardial infarction-associated transcript (MIAT) targets miR200a and VEGF [85, 86]; maternally expressed gene 3 (MEG3) facilitates the ubiquitination and degradation of forkhead box protein M1 (FOXM1) reducin…”
BackgroundBeer, L., Mildner, M., & Ankersmit, H. J. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.03.50 · Cited by 116 · cited 1×
“The secretome consists of all factors actively or passively released from cells; it contains soluble products composed of a proteic soluble fraction (mostly growth factors and cytokines) and a vesicular component, extracellular vesicles (EVs), which transfer proteins, lipids, and genetic material to recipient cells [2…”
BackgroundLin, R.-Z., Moreno-Luna, R., Zhou, B., Pu, W. T., & Melero-Martin, J. M. (2012) · Angiogenesis · doi:10.1007/s10456-012-9272-2 · Cited by 115
Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy
Fatima, F., & Nawaz, M. (2015) · Chinese Journal of Cancer · doi:10.1186/s40880-015-0051-5 · Cited by 114 · cited 1×
“Stem cells can deliver ncRNAs to injured tissues through EVs, thus regulating specific programs of tissue regeneration [83].”
BackgroundMesenchymal Stem Cells-Derived Exosomes for Wound Regeneration
Goodarzi, P., Larijani, B. A., Alavi-Moghadam, S., Tayanloo-Beik, A., Mohamadi-Jahani, F., Ranjbaran, N., Payab, M., Falahzadeh, K., Mousavi, M., & Arjmand, B. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_251 · Cited by 114
Ju, C., Shen, Y., Ma, G., Liu, Y., Cai, J., Kim, I., Weintraub, N. L., Liu, N., & Tang, Y. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9822-0 · Cited by 111
Assessment of a Nuclear Affinity Labeling Method for Tracking Implanted Mesenchymal Stem Cells
Leiker, M., Suzuki, G., Iyer, V., Canty John, M., & Lee, T. (2008) · Cell Transplantation · doi:10.3727/096368908786576444 · Cited by 108
Dabrowski, F. A., Burdzinska, A., Kulesza, A., Sladowska, A., Zolocinska, A., Gala, K., Paczek, L., & Wielgos, M. (2017) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.13432 · Cited by 106
Eirin, A., Zhu, X.-Y., Puranik, A. S., Woollard, J. R., Tang, H., Dasari, S., Lerman, A., van Wijnen, A. J., & Lerman, L. O. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174303 · Cited by 102 · cited 1×
“The enriched angiogenic proteins identified in EVs comprise VEGF, von Willebrand factor (vWF), and transforming growth factor(TGF-) β1 [41, 42].”
BackgroundPrimed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation
Showalter, M. R., Wancewicz, B., Fiehn, O., Archard, J. A., Clayton, S., Wagner, J., Deng, P., Halmai, J., Fink, K. D., Bauer, G., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.119 · Cited by 96
Tasso, R., Gaetani, M., Molino, E., Cattaneo, A., Monticone, M., Bachi, A., & Cancedda, R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.043 · Cited by 87 · cited 1×
“Moreover, the secretome is also affected by the preconditioning/priming of MSCs during cell culture prior to the collection of the conditioned media (CM) [10, 30, 31].”
BackgroundKim, S.-W., Zhang, H.-Z., Kim, C. E., An, H. S., Kim, J.-M., & Kim, M. H. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr328 · Cited by 76 · cited 25×
“FGF-2 modulates angiogenesis with autocrine mechanism [119], together with VEGF, has a potent synergistic effect on the induction of angiogenesis in vivo [120], and supports long-term angiogenic efficacy of AT-MSCs in ischemic mouse tissues [121].”
ResultInfluentialSmall and long non-coding RNAs in cardiac homeostasis and regeneration
Ounzain, S., Crippa, S., & Pedrazzini, T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.010 · Cited by 65 · cited 1×
“Their regulation of tissue healing and repair processes has been wellrecognized [81, 82].”
BackgroundBlanc, L., Barres, C., Bette-Bobillo, P., & Vidal, M. (2007) · Blood · doi:10.1182/blood-2007-04-085845 · Cited by 65 · cited 1×
“These interactions allow intercellular communications [98], chemoattraction [99], and apoptosis [100].”
BackgroundAngiomiRs: MicroRNAs driving angiogenesis in cancer (Review)
Salinas-Vera, Y. M., Marchat, L. A., Gallardo‐Rinc�n, D., Ruíz‐García, E., la Vega, H. A., Echavarr�a‐Zepeda, R., & López‐Camarillo, C. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.4003 · Cited by 64 · cited 1×
“It has been reported that miRNAs target and modulate the expression of regulatory angiogenic genes encoding for cytokines, MMPs, VEGF, PDGF, fibroblast growth factor (FGF), and epidermal growth factor (EGF) [62].”
BackgroundUnsaturated fatty acids induce mesenchymal stem cells to increase secretion of angiogenic mediators
Smith, A. N., Muffley, L. A., Bell, A. N., Numhom, S., & Hocking, A. M. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.24013 · Cited by 62 · cited 1×
“This indicates that fatty acids may affect MSC engraftment to injured tissue as well as MSC secretion of cytokines and growth factors that regulate local cellular responses to injury [101].”
BackgroundThe promise of enhancer-associated long noncoding RNAs in cardiac regeneration
Ounzain, S., & Pedrazzini, T. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.01.014 · Cited by 59 · cited 1×
“Their regulation of tissue healing and repair processes has been wellrecognized [81, 82].”
BackgroundExosomes as nanocarriers for siRNA delivery: paradigms and challenges
Shahabipour, F., Banach, M., & Sahebkar, A. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.62911 · Cited by 59 · cited 1×
“As a result of EVs’ high lipid content, they have an inherent capacity to pass through biological barriers and escape from phagocytosis by the reticuloendothelial system, while being biocompatible and immunologically inert [88, 95].”
BackgroundExtracellular Vesicles Enhance Multiple Myeloma Metastatic Dissemination
Colombo, M., Giannandrea, D., Lesma, E., Basile, A., & Chiaramonte, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133236 · Cited by 51 · cited 2×
“EV uptake can also be affected by lipid composition, with lipid rafts allowing the EVs to fuse into recipient cells [89].”
BackgroundXiang, C., Yang, K., Liang, Z., Wan, Y., Cheng, Y., Ma, D., Zhang, H., Hou, W., & Fu, P. (2017) · Translational research · doi:10.1016/j.trsl.2017.12.003 · Cited by 42 · cited 2×
“Blocking S1P reduced the therapeutic effect of MSCderived EVs [91].”
BackgroundLiu, F. D., Tam, K., Pishesha, N., Poon, Z., & Vliet, K. J. V. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0982-2 · Cited by 39 · cited 1×
“[27], are due to numerous secreted elements collectively referred to as the secretome [28].”
BackgroundMesenchymal stromal cell secretome as a therapeutic strategy for traumatic brain injury
Muhammad, S. A. (2019) · BioFactors · doi:10.1002/biof.1563 · Cited by 39
Sun, X., Luo, L., Feng, L., & Li, D.-S. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.024 · Cited by 37 · cited 1×
“MSC-derived lncRNAs have been shown to support angiogenesis through the endothelial differentiation of MSCs: myocardial infarction-associated transcript (MIAT) targets miR200a and VEGF [85, 86]; maternally expressed gene 3 (MEG3) facilitates the ubiquitination and degradation of forkhead box protein M1 (FOXM1) reducin…”
BackgroundWang, H., Ding, X., Yang, J., Li, S., Zheng, H., Gu, C., Jia, Z., & Li, L. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.02.001 · Cited by 36 · cited 1×
“MSC-derived lncRNAs have been shown to support angiogenesis through the endothelial differentiation of MSCs: myocardial infarction-associated transcript (MIAT) targets miR200a and VEGF [85, 86]; maternally expressed gene 3 (MEG3) facilitates the ubiquitination and degradation of forkhead box protein M1 (FOXM1) reducin…”
BackgroundMunshi, A., Mehic, J., Creskey, M., Gobin, J., Gao, J., Rigg, E., Muradia, G., Luebbert, C., Westwood, C., Stalker, A., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1516-2 · Cited by 36 · cited 1×
“Among these proteins, neuropilin 1 (NRP1) is interestingly known to regulate vasculogenesis, chemotaxis, migration, and invasion [59].”
BackgroundQuantitative proteomic characterization of lung-MSC and bone marrow-MSC using DIA-mass spectrometry
Enes, S. R., Åhrman, E., Palani, A., Hällgren, O., Bjermer, L. H., Malmström, A., Scheding, S., Malmström, J. A., & Westergren‐Thorsson, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-09127-y · Cited by 33
Enhancement of long-term angiogenic efficacy of adipose stem cells by delivery of FGF2
Lee, T., Bhang, S. H., Yang, H. S., La, W.-G., Yoon, H. H., Shin, J., Seong, J. Y., Shin, H., & Kim, B. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.04.004 · Cited by 30 · cited 1×
“FGF-2 modulates angiogenesis with autocrine mechanism [119], together with VEGF, has a potent synergistic effect on the induction of angiogenesis in vivo [120], and supports long-term angiogenic efficacy of AT-MSCs in ischemic mouse tissues [121].”
BackgroundGaetani, M., Chinnici, C. M., Carreca, A. P., Pasquale, C. D., Amico, G., & Conaldi, P. G. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2417 · Cited by 29 · cited 1×
“An unbiased stable isotope labeling by amino acid- (SILAC-) based quantitative proteomic approach in cell culture coupled to LC-MS and validated by functional assays revealed that the secretome of MSCs isolated from fetal skin is superior to that of adult skin [109].”
MethodChatgilialoglu, A., Rossi, M., Alviano, F., Poggi, P., Zannini, C., Marchionni, C., Ricci, F., Tazzari, P. L., Taglioli, V., Calder, P. C., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0487-4 · Cited by 28 · cited 1×
“Supplementing lipids during the culture of human fetal membrane MSCs has been shown to increase cell proliferation rate, angiogenic differentiation, and immunomodulatory properties [104].”
BackgroundMizukami, A., Thomé, C. H., Ferreira, G. A., Lanfredi, G. P., Covas, D. T., Pitteri, S. J., Swiech, K., & Faça, V. M. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00154 · Cited by 28 · cited 1×
“To date, mass spectrometry represents a powerful high-throughput technique enabling the identification and quantification of thousands of proteins present in the MSC secretome [108, 123, 124].”
BackgroundClinical applications of the pedicled anterolateral thigh flap in reconstruction
Lin, C., Wang, C., Ou, K., Chang, S., Dai, N., Chen, S.-G., Chen, T., & Tzeng, Y. (2015) · ANZ Journal of Surgery · doi:10.1111/ans.12973 · Cited by 26 · cited 1×
“miR-210 Mouse bone marrow Promotion of angiogenesis in a mouse myocardial infarction model through the repression of Efna3 expression in endothelial cells [66, 74]”
BackgroundShen, C., Chen, B., Gu, J., Ning, J., Chen, L., Zeng, J., Yi, B., & Lu, K. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.04.013 · Cited by 18 · cited 11×
“Furthermore, macrophage colony-stimulating factor (MCSF), interleukin-1 receptor antagonist (IL-1ra), and SDF-1a secretion were significantly higher in TNF-α- and IFN-γstimulated perinatal MSCs but lower than BM-MSCs while monocyte chemotactic protein-1 (MCP-1) was significantly higher in perinatal MSCs than BM-MSCs w…”
BackgroundInfluentialCavallini, C., Zannini, C., Olivi, E., Tassinari, R., Taglioli, V., Rossi, M., Poggi, P., Chatgilialoglu, A., Simonazzi, G., Alviano, F., et al. (2018) · Cell Transplantation · doi:10.1177/0963689717723016 · Cited by 14 · cited 1×
“In addition, when these MSCs are exposed to EVs obtained from lipidsupplemented culture, cell migration rates improve as assessed by a wound-healing assay [105].”
BackgroundBone marrow-derived mesenchymal stromal cell: what next?
Borges, F. T., Convento, M. B., & Schor, N. (2018) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s147804 · Cited by 14 · cited 1×
“It has also been reported that MSCs lose their multipotency and undergo senescence during prolonged in vitro culture [102] and this can partly be attributed to a decrease in omega-6 fatty acids which in turn decreases membrane fluidity [103].”
Background
Cited by
Chronic Diabetic Wounds and Their Treatment with Skin Substitutes
Holl, J., Kowalewski, C., Zimek, Z., Fiedor, P., Kaminski, A., Oldak, T., Moniuszko, M., & Eljaszewicz, A. (2021) · Cells · doi:10.3390/cells10030655 · Cited by 351
“This strong regenerative effect is associated primarily with MSC ability to improve neovascularization of the wound via paracrine activity in addition to their well-characterized anti-inflammatory effects [113].”
BackgroundGalderisi, U., Peluso, G., & Di Bernardo, G. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10231-w · Cited by 240
Miceli, V., Bulati, M., Iannolo, G., Zito, G., Gallo, A., & Conaldi, P. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020763 · Cited by 175
“MSC effects depend both on tissue source [30,31] and on how they are produced and administered.”
BackgroundAlvites, R., Branquinho, M., Sousa, A. C., Lopes, B., Sousa, P., & Maurício, A. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020381 · Cited by 174
“This fact reveals that, in addition to their ability to influence neighboring cells and tissues through a cell-to-cell interaction, MSCs also act through a paracrine signaling mechanism [132].”
BackgroundRecent advances to enhance the immunomodulatory potential of mesenchymal stem cells
Sarsenova, M., Kim, Y., Raziyeva, K., Kazybay, B., Ogay, V. B., & Saparov, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010399 · Cited by 136
Metadata
- Authors
- Maacha, S., Sidahmed, H., Jacob, S., Gentilcore, G., Calzone, R., Grivel, J.-C., & Cugno, C.
- Affiliations
- Sidra Medical and Research Center (QA)
- Corresponding author
- Cugno, Chiara
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2020-03-09
- Volume
- 2020
- Pages
- 1-12
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- PMC
- PMC7085399
- OpenAlex
- W3010082761
- Cited by
- 259
- References
- 132
- Citations by year
- 2026: 28 · 2025: 29 · 2024: 46 · 2023: 39 · 2022: 52 · 2021: 53 · 2020: 12
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cells International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Qatar National Research Fund (NPRP12S-0304-190225)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, angiogenesis, paracrine signaling, extracellular vesicles, growth factors, cytokines, cell-free therapy, tissue damage, bone marrow-derived MSCs, adipose-derived MSCs, preconditioning, tissue repair, immunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.